By
Jaclyn Jaeger2020-02-05T19:53:00
The Federal Trade Commission and Food and Drug Administration have signaled they will be increasing their oversight of any potential antitrust behavior in the biologics market.
2025-01-15T19:05:00Z By Oscar Gonzalez
The U.S. Food and Drug Administration announced Wednesday it has revoked authorization for color additive Red No. 3 from food, beverages, and drugs. Health concerns over dye have existed since it was banned from cosmetics in 1990 after it was found that large doses led to the development of cancer ...
2020-01-30T21:47:00Z By Jaclyn Jaeger
The U.K. Competition and Markets Authority won a victory in a decision by Europe’s high court, ruling GlaxosmithKline’s entering of a financial deal with industry rivals to delay the generic version of its drugs violates EU competition law.
2025-11-14T22:29:00Z By Adrianne Appel
A California privacy agency plans to seek a whistleblower law, to encourage corporate employees and others to step forward with complaints about egregious privacy violations at their workplaces.
2025-11-14T22:59:00Z By Neil Hodge
The U.K. has set out a new blueprint for AI regulation, which aims to slash bureaucracy and ramp up the safe adoption of new and emerging technology to unlock potential and boost investment.
2025-11-13T21:33:00Z By Oscar Gonzalez
The U.S. Consumer Financial Protection Bureau (CFPB) proposed a rule change that would narrow anti-discrimination requirements for the financial industry. This comes as the Trump administration attempts to shutter the agency may finally come to pass.
2025-11-11T21:30:00Z By Neil Hodge
The U.K.’s financial services regulator will take a more central role as part of the government’s plans to simplify—and improve—efforts to clamp down on money laundering and terrorist financing.
Site powered by Webvision Cloud